These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1474168)

  • 1. Comparison of pentoxifylline pharmacokinetics between smokers and nonsmokers.
    Mauro VF; Mauro LS; Hageman JH
    J Clin Pharmacol; 1992 Nov; 32(11):1054-8. PubMed ID: 1474168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of pentoxifylline pharmacokinetics by cimetidine.
    Mauro VF; Mauro LS; Hageman JH
    J Clin Pharmacol; 1988 Jul; 28(7):649-54. PubMed ID: 3216031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients.
    Rames A; Poirier JM; LeCoz F; Midavaine M; Lecocq B; Grange JD; Poupon R; Cheymol G; Jaillon P
    Clin Pharmacol Ther; 1990 Mar; 47(3):354-9. PubMed ID: 2178853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic disposition of intravenous and oral pentoxifylline in horses.
    Crisman MV; Wilcke JR; Correll LS; Irby MH
    J Vet Pharmacol Ther; 1993 Mar; 16(1):23-31. PubMed ID: 8478997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple-dose pharmacokinetics of pentoxifylline and its metabolites during renal insufficiency.
    Paap CM; Simpson KS; Horton MW; Schaefer KL; Lassman HB; Sack MR
    Ann Pharmacother; 1996; 30(7-8):724-9. PubMed ID: 8826548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of crushed extended-release pentoxifylline tablets: bioavailability and adverse effects.
    Cleary JD; Evans PC; Hikal AH; Chapman SW
    Am J Health Syst Pharm; 1999 Aug; 56(15):1529-34. PubMed ID: 10478991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of intranasal and intratracheal pentoxifylline in rabbits.
    Adcock KG; Kyle PB; Deaton JS; Olivier JH; Hogan SM
    Pharmacotherapy; 2007 Feb; 27(2):200-6. PubMed ID: 17253910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetic analysis of novel sustained-release dosage forms of pentoxifylline in healthy subjects.
    Raz I; Ben-David J; Hussein Z; Samara E
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):206-8. PubMed ID: 3403100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of physical activity on absorption and metabolism of an orally applied drug (pentoxifylline).
    Adam P; Richter E; Adam O; Forth W
    Eur J Med Res; 1999 Dec; 4(12):525-8. PubMed ID: 10611057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of pentoxifylline and its 5-hydroxyhexyl metabolite after oral and intravenous administration of pentoxifylline to healthy adult horses.
    Liska DA; Akucewich LH; Marsella R; Maxwell LK; Barbara JE; Cole CA
    Am J Vet Res; 2006 Sep; 67(9):1621-7. PubMed ID: 16948611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability study of two controlled-release pentoxifylline tablet preparations.
    Yuen KH; Wong JW; Peh KK; Julianto T; Choy WP
    Drug Dev Ind Pharm; 2000 Jul; 26(7):803-7. PubMed ID: 10872103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking accelerates absorption of inhaled neutrophil elastase inhibitor FK706.
    Koizumi F; Murakami M; Kageyama H; Katashima M; Terakawa M; Ohnishi A
    Clin Pharmacol Ther; 1999 Nov; 66(5):501-8. PubMed ID: 10579477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of pentoxifylline and its metabolites by standardbred mares.
    Kwong EC; Chen FC; Young LM
    Can J Vet Res; 1989 Apr; 53(2):147-53. PubMed ID: 2713780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of intravenous and oral pentoxifylline in healthy subjects.
    Beermann B; Ings R; Månsby J; Chamberlain J; McDonald A
    Clin Pharmacol Ther; 1985 Jan; 37(1):25-8. PubMed ID: 3965236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interconversion and tissue distribution of pentoxifylline and lisofylline in mice.
    Wyska E; Pekala E; Szymura-Oleksiak J
    Chirality; 2006 Aug; 18(8):644-51. PubMed ID: 16721727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of pentoxifylline after oral administration of a sustained release tablet at two different times of the day.
    Srinivasu P; Rambhau D; Rao BR; Rao YM
    Arzneimittelforschung; 1999 Sep; 49(9):750-3. PubMed ID: 10514902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of bupropion and its metabolites in cigarette smokers versus nonsmokers.
    Hsyu PH; Singh A; Giargiari TD; Dunn JA; Ascher JA; Johnston JA
    J Clin Pharmacol; 1997 Aug; 37(8):737-43. PubMed ID: 9378846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men.
    Crowley JJ; Cusack BJ; Jue SG; Koup JR; Park BK; Vestal RE
    J Pharmacol Exp Ther; 1988 May; 245(2):513-23. PubMed ID: 3367304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosing regimen and hematologic effects of pentoxifylline and its active metabolites in normal dogs.
    Rees CA; Boothe DM; Boeckh A; Wilkie S; Esparza T; Green R
    Vet Ther; 2003; 4(2):188-96. PubMed ID: 14506595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and clinical efficacy of oral morphine solution and controlled-release morphine tablets in cancer patients.
    Thirlwell MP; Sloan PA; Maroun JA; Boos GJ; Besner JG; Stewart JH; Mount BM
    Cancer; 1989 Jun; 63(11 Suppl):2275-83. PubMed ID: 2720576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.